Lung inflammatory cells of patients with idiopathic pulmonary fibrosis (IPF) were evaluated for their ability to injure 5'Crlabeled AKD alveolar epithelial cells in the presence and absence of IPF alveolar epithelial lining fluid (ELF). The IPF cells were spontaneously releasing exaggerated amounts of superoxide (O2) and hydrogen peroxide (H202) compared with normal (P < 0.02). Cytotoxicity of the AKD cells was markedly increased when the IPF inflammatory cells were incubated with autologous ELF (P < 0.02). The majority of IPF patients had ELF myeloperoxidase levels above normal (P < 0.002). Incubation of IPF ELF with AKD cells in the presence of H202 caused increased cellular injury (P < 0.01 compared with control), which was suppressed by methionine, a myeloperoxidase system scavenger. IPF patients with high concentrations of ELF myeloperoxidase deteriorated more rapidly than those with low ELF myeloperoxidase (P < 0.05). Thus, IPF is characterized by an increased spontaneous production of oxidants by lung inflammatory cells, the presence of high concentrations of myeloperoxidase in the ELF of the lower respiratory tract, and a synergistic cytotoxic effect of alveolar inflammatory cells and ELF on lung epithelial cells, suggesting oxidants may play a role in causing the epithelial cell injury of this disorder.
Introduction
Idiopathic pulmonary fibrosis (IPF)' is a chronic, often fatal inflammatory interstitial lung disorder characterized by an accumulation ofalveolar macrophages and neutrophils in the lower respiratory tract, parenchymal cell injury, and fibrosis of the alveolar walls (1) (2) (3) (4) (5) (6) (7) . One prominent feature of IPF is the marked changes to the alveolar epithelial cells, including destruction of type I alveolar epithelial cells and repopulation of the epithelial surface by type II alveolar epithelial cells and bronchiolar epithelial cells (8) .
Alveolar macrophages and neutrophils dominate the inflammatory cell population in the lower respiratory tract of patients with IPF (9) . Because both cell types are capable ofinducing oxidant-mediated lung parenchymal cell cytotoxicity (10, 1 1), one mechanism to explain the epithelial cell injury associated with IPF is the spontaneous release oftoxic oxidants by alveolar macrophages and neutrophils. In addition, when activated, neutrophils can also release myeloperoxidase, a 11 5,000-dalton pro-tein which can interact with H202, a product of both mononuclear phagocytes and neutrophils, to form the highly toxic hypohalide anion (12) (13) (14) (15) (16) (17) .
In this regard, it is reasonable to hypothesize that the alveolar epithelial cell injury that characterizes IPF may result, at least in part, from an enhanced oxidant burden that may exist in the lower respiratory tract ofthese patients. To evaluate this concept, inflammatory cells recovered by bronchoalveolar lavage from the lower respiratory tract of patients with IPF were evaluated for their ability to spontaneously cause oxidant-mediated alveolar epithelial cell cytotoxicity in the presence and absence of epithelial lining fluid (ELF) from the same individuals. The results indicate that inflammatory lung cells and ELF of individuals with IPF have a synergistic cytotoxic effect on lung epithelial cells that is mediated through oxidant mechanisms. Furthermore, not only are the inflammatory lung cells in IPF spontaneously releasing high levels of toxic oxidants, but the ELF markedly enhances the cytotoxic potential of the oxidants by providing a source of myeloperoxidase in the epithelial fluid lining the alveolar epithelium.
Methods

Study population
The study population consisted of 44 patients with IPF and 11 normal subjects.
IPF. Patients were diagnosed as having IPF according to previously defined clinical and histologic criteria (1) . All individuals with IPF (24 men, 20 women) had mild or midcourse disease, the average age was 50±2 yr,2 and all were nonsmokers (n = 31) or ex-smokers (n = 13; defined as having discontinued cigarette smoking for at least 1 yr before initial evaluation). Of the 44 individuals, 33 were not being treated, 9 were receiving prednisone (30±5 mg daily), and 2 were receiving cyclophosphamide (120±20 mg daily). All had chest roentgenograms that demonstrated diffuse reticulonodular infiltrates. On the average, the fol-ELF was obtained by collecting the cell-free supernatant of the lavage fluid, separating insoluble materials by centrifugation at 25 ,000 g for 15 min, and concentrating the fluid 100-fold by pressure ultrafiltration on a YM-l0 membrane (Amico Corp., Lexington, MA). All data relating to the evaluation of molecules in the ELF are expressed relative to the amount of albumin (radial immunodiffusion, Calbiochem-Behring Corp., San Diego, CA) present in the concentrated fluid.
Cytotoxicity assay
The epithelial cell strain AKD (ATCC CCL 150, American Type Culture Collection, Rockville, MD), derived from cat lung (19) 
Lung inflammatory cell-induced epithelial cell cytotoxicity
To evaluate the ability of lung inflammatory cells spontaneously to injure lung epithelial cells, cells recovered by lavage of normals or patients with IPF were incubated with 31Cr-labeled AKD cells under conditions described above. The labeled cells were incubated for 16 h at 370C (0.2 X 106 per well) in 0.5 ml EBSS plus one of the following conditions: (a) 0.1 ml EBSS (control), (b) ELF (0.1 ml of 100-fold concentrated lavage fluid containing 0.2 Mg of albumin), (c) 106 inflammatory cells suspended in 0.1 ml RPMI (M. A. Bioproducts), or (d) ELF + inflammatory cells in a total of 0.1 ml. In each of these conditions, parallel plates were incubated with 1,000 U of catalase (an inhibitor of H202) or 300 U of superoxide dismutase (an inhibitor ofO°). After incubation, a cytotoxicity index was calculated as described above.
Spontaneous release ofoxidants by lung inflammatory cells
Spontaneous release of superoxide and hydrogen peroxide by lung inflammatory cells was assessed using ferricytochrome c to detect superoxide and phenol red to detect H202 (20) (21) (22) . Alveolar inflammatory cells obtained by bronchoalveolar lavage were allowed to adhere in 24-well tissue culture plates (Falcon Labware) at a concentration of 0.5 X 106 cells per well in Dulbecco's at 37°C, 5% C02, for 1 h. The supernatant was then discarded. For the measurement of superoxide release, 0.5 ml ofHanks' balanced salt solution (HBSS; Gibco Diagnostic Laboratories) containing 80 MM ferricytochrome c (type III, Sigma Chemical Co., St.
Louis, MO) was added, and after incubation for 30 min at 370C, the amount of°2 in the supernatant was quantified at 550 nm. For the measurement of H202 release, HBSS containing 0.28 mM phenol red, 8.5 U/ml horseradish peroxidase (type II, Sigma Chemical Co.) was added and after incubation for 30 min at 37°C, the amount of H202 in the supernatant was quantified in the phenol red solutions after 1OJl of 1 N NaOH were added to the samples and absorbance was measured spectrophotometrically at a wavelength of 610 nm. The concentrations of hydrogen peroxide were determined according to a standard curve, using various dilutions of reagent grade 30% H202.
Measurement ofmyeloperoxidase and catalase in ELF
Myeloperoxidase activity in ELF was quantitated by the 0-dianisidine method (23). 1 U of activity was defined as that amount of enzyme inducing a change in absorbance of the O-dianisidine solution equal to 0.001 absorbance U/min at a wavelength of 460 nm (15) . The values of myeloperoxidase were expressed as a ratio to albumin content to account for the concentration of the lavage fluid. Catalase activity in ELF was quantified using the method described by Abei (24) . 1 U of catalase activity was defined as the rate constant of the first-order reaction, and the results were expressed as a ratio to albumin content.
Purification ofmyeloperoxidase from neutrophils
Myeloperoxidase was purified according to a modification ofthe method described by Olsen et al. (25) . All reagents used were ofanalytical reagentgrade purity. Human leukocytes were obtained by leukapheresis ofnormal subjects and neutrophil granules were extracted as described by Baugh and Travis (26) . The granules were sonicated (Sonifier, Ultrasonics Inc., Plainview, NY) in 0.2 M sodium acetate, 1 M NaCI at pH 4.0, three times for 20 s. The granule extract was centrifuged at 30,000 g for 60 min and the supernatant was dialyzed against 50 mM Tris-HCl, pH 8.0, 50 mM NaCl. This material was then centrifuged (30,000 g for 60 min) and the supernatant was applied to an Elastin-Sepharose column (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated in 50 mM Tris-HCI, pH 8.0, 50 mM NaCl. The unbound protein was collected and applied to a concanavalin A-Sepharose column (Pharmacia Fine Chemicals), equilibrated with 0.2 M sodium acetate, 0.5 M CaCl2, 5 mM MnCl2, 5 mM MgCl2, and 0.05% cetyltrimethylammonium bromide at pH 5.6. The column was washed thoroughly in the starting buffer until the optical density of the eluate was < 0.02 absorbance U at 280 nm. The myeloperoxidase was then eluted from the column with the starting buffer containing 0.2 M 1-0-methyl a-D-glucopyranoside. The eluted myeloperoxidase was concentrated by ultrafiltration on an Amicon YM-10 membrane and applied to a Sephadex G-100 column equilibrated in starting buffer. The absorbance ratio at 430 nm/280 nm of the purified myeloperoxidase was 0.82.
In vitro model ofoxidant-mediated epithelial cell cytotoxicity
In order to evaluate the mechanism(s) by which the ELF ofpatients with IPF might augment oxidant-mediated cytotoxicity towards lung epithelial cells, an in vitro oxidant-generating system was developed. EBSS (500 jul), supplemented with 55 mM glucose, was incubated with the cells and the production of oxidants was initiated by the addition of 0.05 ml of glucose oxidase (23 mU/ml, Boehringer-Mannheim Biochemicals, Indianapolis, IN) to the test media and incubated at 37°C, 5% CO2 for 8 h. At the end of the incubation period, the cytotoxicity index was determined as described above. Hydrogen peroxide produced by this system was quantitated spectrophotometrically at a wavelength of 610 nm by incubating 0.55 ml of media containing 55 mM glucose, glucose oxidase at varying concentrations, 0.95 ml of 0.28 mM phenol red, 8.5 U/ml horseradish peroxidase followed by 10 ,l of 1 N NaOH after 60 min at 37°C. Superoxide production was assessed by measuring the reduction of 0.95 ml of 80 gM ferricytochrome c at 550 nm after 60 min of incubation with 0.55 ml of the glucose, glucose-oxidase solutions. To determine whether myeloperoxidase might have a direct effect on lung epithelial cells or might augment H202-induced cytotoxicity to the lung epithelial cells, myeloperoxidase (100 gl, 80 U/ml) was incubated with the cells in the presence ofeither media alone or media and the oxidantgenerating system (55 mM glucose, 23 mU/ml glucose oxidase) for 8 h at 37°C, followed by determination of the cytotoxicity index.
Effect ofELF ofpatients with IPF on augmenting epithelial cell cytotoxicity To determine whether ELF of patients with IPF might modulate oxidantmediated epithelial cell cytotoxicity, ELF was incubated with the lung epithelial cells in the presence or absence ofthe in vitro oxidant-generating system. EBSS (500 Ml), supplemented with 55 mM glucose was incubated 1666 with the 5"Cr-labeled AKD cells. The production of oxidants was initiated with 23 mU/ml glucose oxidase and incubated for 8 h at 370C. ELF (100 Ml of concentrated lavage fluid containing 2 mg/ml albumin) from normal subjects or patients with IPF was then added to the cells in the presence or absence of the oxidant-generating system, incubated for 8 h at 370C, and the cytotoxicity index was determined as described above.
To evaluate the role played by the hypohalide radical as the mechanism by which IPF ELF augmented oxidant-mediated epithelial cell cytotoxicity, the cytotoxicity index was determined using cells incubated (8 h at 370C) with and without methionine (250MuM), a scavenger ofoxidants derived from the myeloperoxidase-H202-halide system (27) in the presence of(a) the oxidant-generating system alone, (b) the oxidant-generating system and myeloperoxidase (100MlA, 80 U/ml), or (c) with the oxidantgenerating system and IPF ELF (100 Al). As a control for other oxidants that may play a role in this process, the cytotoxicity index was determined after the cells were incubated (8 h at 370C) in the presence ofthe oxidantgenerating system and (a) IPF ELF (100 Ml) + 1,000 U/ml catalase, (b) IPF ELF (100 Ml) + 1,000 U/ml heated catalase (100C for 15 min), (c) IPF ELF (100 Ml) + 10 ug/ml superoxide dismutase, (d) IPF ELF (100 Ml) + 0.5 mM sodium azide (an inhibitor of myeloperoxidase), or (e) heated IPF ELF (100 Ml; 100IC for 15 min). Relationship ofELF myeloperoxidase levels to clinical outcome
To evaluate a possible relationship between ELF myeloperoxidase levels and the clinical outcome of patients with IPF, the patients were divided into two groups at their initial evaluation, including (a) those with ELF myeloperoxidase < 10 U/mg albumin (the highest level seen in normals) and (b) those with ELF myeloperoxidase > 10 U/mg albumin. The patients were then reevaluated at intervals (minimum ofthree) over at least I yr or longer after the initial evaluation. The percent absolute value (in milliliters) ofthe vital capacity at each interval was then used to determine the rate ofchange ofvital capacity per year using linear regression analysis.
Statistical analysis ofdata
All data composed of normally distributed variables was expressed as the arithmetic mean±the standard error of the mean. ELF myeloperoxidase data were analyzed with the Mann-Whitney test using a twotailed 5% significance level.
Results
Cytotoxicity induced by inflammatory lung cells and ELF of patients with IPF. The ELF, and the alveolar inflammatory cells obtained from normal subjects, were not toxic to AKD cells. In contrast, whereas the inflammatory cells of patients with IPF were only mildly toxic to the AKD cells and the ELF was not at all toxic, together the inflammatory cells and the ELF of patients with IPF clearly acted synergistically to injure lung epithelial cells ( Fig. 1, P Model culture system ofepithelial cell cytotoxicity. The model culture system used to evaluate lung epithelial cell cytotoxicity used an artificial oxidant-generating system that produced H202 but not superoxide (Fig. 4 A) that H202 is cytotoxic to most cells in a concentration-dependent fashion, when increasing amounts of glucose oxidase were added to the epithelial cell cultures, an increased amount ofcytotoxicity was observed (Fig. 4 B) . This cytotoxicity was completely suppressed by the addition of 1000 units/ml catalase. Ability ofELF to modulate oxidant-mediated injury to lung epithelial cells. ELF from normal subjects and patients with IPF was not directly toxic to the lung epithelial cells (Fig. 6) . When cells were incubated with the H202-generating system alone, a cytotoxicity index of 30%±4% resulted. When the target cells were exposed to this H202-generating system in the presence of ELF from normal subjects, there was a significant reduction in the cytotoxicity index (Fig. 6, P < 0.01) . Similarly, small amounts of IPF ELF containing myeloperoxidase (152±1 1 U/mg albumin) protected the target cells against H202-induced lung epithelial cell injury, likely through the action of antioxidant molecules known to be present in ELF (see Discussion). However, increasing amounts of IPF ELF markedly enhanced the H202-mediated cytotoxicity of lung epithelial cells (Fig. 7) .
Rolefor myeloperoxidase and the hypohalide anion in IPF oxidant-mediated lung cell injury. The ability of IPF ELF to augment H202-mediated injury to the lung parenchymal cells correlated with the concentration of myeloperoxidase in the ELF (r = 0.68, P < 0.001; Fig. 8 ). In this regard, for those patients with IPF in which the ELF did not augment oxidant-mediated injury to the lung cells, the myeloperoxidase concentration of the ELF was only slightly increased above the range found in normal subjects (10.3±2.9 U/mg of albumin). In contrast, for those IPF patients in which the ELF enhanced oxidant-mediated injury, the myeloperoxidase concentration in ELF was significantly increased (32.6±10.5 U/mg of albumin, P < 0.05).
The ability of IPF ELF to increase the H202-mediated lung epithelial cell injury was not associated with a deficiency in the anti-H202 defenses of ELF, because the catalase content was threefold increased in IPF ELF when compared with normal ELF (433±109 vs. 154±22 U/mg of albumin, P < 0.05).
Further evidence that myeloperoxidase mediated the en- IPF ELF (ILI/ml test media) Figure 7 . Effect of increasing amounts of IPF ELF on H202-mediated cytotoxicity to lung epithelial cells. ''Cr-labeled lung epithelial cells were incubated (8 h at 37°C) with glucose (55 mM) and glucose oxidase (23 mU/ml) alone or in the presence of increasing amounts of ELF (myeloperoxidase activity, 76±6 U/ml ELF) from a patient with IPF.
hancement of oxidant injury to lung epithelial cells by IPF ELF was provided by the observations that (a) whereas the oxidantgenerating system plus IPF ELF caused a cytotoxicity index of 72±3%, catalase completely inhibited IPF ELF-mediated cytotoxicity (0±1%, P < 0.001) while heat-inactivated catalase had no effect (64±4%, P < 0.2), (b) superoxide dismutase did not suppress the IPF ELF-mediated cytotoxicity (72±2%, P < 0.5); (c) azide, an inhibitor of myeloperoxidase, was partially protective (42±2%, P < 0.01); (d) heating the IPF ELF suppressed its ability to enhance the oxidant-mediated epithelial cell injury (14±3%, P < 0.001); and (e) when purified human myeloperoxidase was added to ELF that did not augment H202-mediated injury (final concentration 60 U/mg of albumin), the Because the major mechanism by which myeloperoxidase effects injury is through its ability to convert (in the presence of a halide) H202 to the very toxic hypohalide radical, it is reasonable to hypothesize that the ability of IPF ELF to augment H202-mediated injury to lung epithelial cells is through the hypohalide anion. In this context, the cytotoxicity studies were repeated in the presence or absence of methionine, a scavenger of products of the myeloperoxidase system (27). Whereas the hydrogen peroxide-generating system alone induced a cytotoxicity index of 25±3%, methionine was unable to lower the index. However, in the presence of either purified myeloperoxidase or ELF from patients with IPF, where the cytotoxicity of the hydrogen peroxide generating system was markedly enhanced, the addition of methionine completely suppressed the lung cell injury (Fig. 9) .
Correlation of ELF myeloperoxidase concentrations and functional outcome ofpatients with IPF. 18 patients with IPF underwent multiple respiratory physiologic determinations over an interval of at least 1 yr after ELF myeloperoxidase concentrations had been quantitated. Of these patients, eight had myeloperoxidase concentrations within the range found in normal subjects (. 10 U/mg of albumin) and 10 had increased levels of ELF myeloperoxidase (> 10 U/mg of albumin). Strikingly, the rate of deterioration of the vital capacity was more rapid in those patients with increased ELF myeloperoxidase than in those patients with low levels of ELF myeloperoxidase (-397±100 vs. -44±50 ml/yr P < 0.05, Fig. 10 ).
Discussion
IPF is characterized by marked alterations in the normal alveolar epithelium consisting of a loss of type I epithelial cells and replacement by cuboidal, often metaplastic cells (1, 8, (28) (29) (30) (31) (32) (33) . Although the mechanisms by which the epithelium attempts to repair itself are unknown, the intensity of inflammation occurring in the alveolar structures of these patients suggests that in- flammatory cell-mediated oxidant injury may play a role in the initial injury to the normal alveolar epithelium. Consistent with this hypothesis, this study demonstrates that the inflammatory cells that accumulate on the alveolar surface in IPF spontaneously release increased amounts ofthe oxidants°2 and H202 and, in the presence of their alveolar ELF, can induce lung epithelial cell inury likely through a myeloperoxidase-mediated hypohalide radical related process. Several lines ofevidence suggest that the epithelial cell injury induced by IPF lung inflammatory cells and ELF was related to oxidants derived from the H202-myeloperoxidase reaction: (a) catalase, but not heat-inactivated catalase, reduced the cytotoxicity, suggesting that the effect of catalase was related to H202 degradation rather than a nonspecific effect such as alteration ofinflammatory cell adherence to the target cells; (b) heat inactivation of IPF ELF blocked its cytotoxicity enhancing effect, suggesting that the ELF-induced injury was related to enzymatic activity; (c) addition of a myeloperoxidase inhibitor to IPF ELF markedly reduced its ability to enhance inflammatory cell-mediated cytotoxicity; and (d) inflammatory lung cells from patients with IPF spontaneously released increased amounts of O°and H202.
Evidence ofepithelial cell injury in IPF. A variety of observations at the optical and electron-microscopic levels have demonstrated that prominent alveolar epithelial cell injury is a characteristic feature of IPF (1, 8, (28) (29) (30) (31) (32) (33) (1, 8, 31) .
Mechanisms of epithelial cell injury in IPF. Together, the present investigation and a variety ofdiverse in vivo and in vitro studies are consistent with the concept that alveolar epithelial cell injury in IPF is mediated through inflammatory cell produced oxidants. First, experimental animal studies with the intratracheal instillation of either oxidant-generating enzyme systems (35) (36) (37) or neutrophil activators, such as phorbol myristate acetate (36) (37) (38) , formylated norleu-leu-phe (36, 37) , and immune complexes (39, 40) , have demonstrated that an oxidant burden in the lower respiratory tract results in severe lung parenchymal cell damage that includes damage to alveolar epithelial cells, epithelial cell death, and desquamation (35) (36) (37) (38) . Furthermore, these changes are followed by the appearance ofsevere interstitial fibrosis (35, 38) , suggesting that oxidants can initiate lung parenchymal changes similar to the histologic changes characteristic of IPF.
Second, IPF is characterized by an accumulation of inflammatory cells in the lower respiratory tract (1, 9, 28-31, 41), including alveolar macrophages, neutrophils, and eosinophils, all of which are capable of producing oxidants (20, (42) (43) (44) (45) (46) (47) (48) .
Third, inflammatory cells recovered from the lower respiratory tract of patients with IPF are spontaneously releasing increased amounts of O2 and H202. Because these cells are present in increased numbers in the lower respiratory tract of patients with IPF (1, 9, 41), it is likely that the oxidant burden at the alveolar epithelial surface is increased manyfold over normal. Although the mechanisms responsible for the increased oxidant release by IPF alveolar inflammatory cells are not known, it has been documented that immune complexes are present in the lungs of patients with IPF (49-5 1) . In that immune complexes are a potent stimulus of oxidant production by macrophages, neutrophils, and eosinophils (42, (52) (53) (54) , it is reasonable to conclude that immune complexes may contribute to the enhanced lung inflammatory cell release ofoxidants in the lower respiratory tract of these patients.
Fourth, peroxidase activity was found in increased amounts in the ELF of the majority of patients with IPF. Although the source of the peroxidase is unknown, the significant correlation between the amount ofELF peroxidase activity and the number of neutrophils recovered from the lower respiratory tract suggests that most ofthe peroxidase activity was derived from neutrophils, cells known to have large amounts of myeloperoxidase (13) .
This concept is consistent with the knowledge that immune complexes (53, 55) and neutrophil chemotactic factors (51) , both present in the lungs of patients with IPF (49) (50) (51) , are potent stimuli ofneutrophil degranulation, including the release ofmyeloperoxidase (53, 55, 56 (Fig. 7) , which is in makred contrast with the antioxidant protective effect known to be present in the ELF of normal subjects (63, 64) . The mechanism by which normal ELF protects lung cells against H202 is through conversion of H202 to H20 by catalase (46). However, the enhanced oxidant injury induced by IPF ELF was not associated with a deficiency ofantioxidants, because the catalase concentration of IPF ELF was consistently two to three times the concentration of catalase in normal ELF. No significant difference in catalase concentration was found between IPF ELF that decreased H202 cytotoxicity and IPF ELF that increased the cytotoxicity. Furthermore, the addition ofpurified human myeloperoxidase to IPF ELF that did not spontaneously enhance oxidant cytotoxicity provided the ELF with the capacity to markedly enhance H202-mediated cytotoxicity. These studies suggest that myeloperoxidase can overwhelm the antioxidant properties of ELF and mediate lung cell damage.
The concept that the hypohalous anion generated at the alveolar epithelial surface in IPF may contribute to the lung epithelial cell injury is supported by the knowledge that myeloperoxidase is capable of markedly increasing the cytotoxicity of H202 for a variety ofmammalian cells (15) (16) (17) (58) (59) (60) (61) (62) including lung parenchymal cells (35) .
Many pieces of evidence suggest that the oxidant-mediated cytotoxicity enhancing characteristics of IPF ELF are related to the generation of hypohalous anion. First, the cytotoxicity-enhancing properties of IPF ELF were dependent on the presence of H202 but not O', in that superoxide dismutase did not alter the cytotoxicity. Second, IPF ELF myeloperoxidase levels showed a significant correlation with the cytotoxic potential of ELF. Third, heat-inactivating the IPF ELF markedly reduced its cytotoxic potential, as did sodium azide, a potent myeloperoxidase inhibitor, suggesting that myeloperoxidase mediated the oxidant-enhancing properties of IPF ELF. Fourth, the oxidants produced by the reaction of H202 and myeloperoxidase include singlet oxygen and the hypohalous anion, however, at pH 7.4 only the hypohalous anion is produced in detectable amounts (65) . Finally, methionine, a known scavenger of the hypohalous anion, provided the epithelial cells with complete protection against the IPF ELF. Together, these data suggest that the mechanisms by which IPF ELF increase epithelial cell cytotoxicity likely relate to the formation of the highly reactive hypohalous anion. This toxic radical is capable of oxidizing a variety of sites in molecules, including sulfhydryl groups, thioethers such as methionine, aromatic and nitrogenous compounds, porphyrins, and nucleotides, resulting in alterations of critical cellular components and cell death (27, (66) (67) (68) . Because In the context of the above, it is reasonable to conclude that alveolar epithelial cell injury in IPF is likely mediated, at least in part, by oxidants generated by the H202-myeloperoxidasehalide reaction at the alveolar epithelial surface. In this regard, strategies to reduce the oxidant burden in IPF may be beneficial in decreasing alveolar epithelial cell injury and consequently reduce the progressive deterioration of these patients.
